{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:15:23Z","timestamp":1786997723108,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.trim.2025.102343","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T23:03:36Z","timestamp":1765753416000},"page":"102343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rituximab-based antibody mediated rejection therapy modestly reduces Xenoreactive antibodies: Implications for pig-to-human xenotransplantation"],"prefix":"10.1016","volume":"94","author":[{"given":"Szu-Tsen","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent P.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Dustin","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanansayan","family":"Shanmuganayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Meudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Robert R.","family":"Redfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Dominko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Aufhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.trim.2025.102343_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08998280.2012.11928783","article-title":"A brief history of cross-species organ transplantation","volume":"25","author":"Cooper","year":"2012","journal-title":"Proc. (Baylor Univ. Med. Cent.)"},{"issue":"1","key":"10.1016\/j.trim.2025.102343_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ajt.16780","article-title":"Kidney transplantation from triple-knockout pigs expressing multiple human proteins in cynomolgus macaques","volume":"22","author":"Ma","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2025.102343_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/xen.12166","article-title":"Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model","volume":"22","author":"Higginbotham","year":"2015","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trim.2025.102343_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ajt.12562","article-title":"One-year heterotopic cardiac xenograft survival in a pig to baboon model","volume":"14","author":"Mohiuddin","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2025.102343_bb0025","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/ajt.15329","article-title":"Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion","volume":"19","author":"Kim","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"7982","key":"10.1016\/j.trim.2025.102343_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.trim.2025.102343_bb0035","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa2120238","article-title":"Results of two cases of pig-to-human kidney xenotransplantation","volume":"386","author":"Montgomery","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.trim.2025.102343_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically modified porcine-to-human cardiac xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.trim.2025.102343_bb0045","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.medj.2024.05.003","article-title":"Cellular dynamics in pig-to-human kidney xenotransplantation","volume":"5","author":"Pan","year":"2024","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.trim.2025.102343_bb0050","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0167-5699(93)90261-I","article-title":"Interaction of the natural anti-gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans","volume":"14","author":"Galili","year":"1993","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.trim.2025.102343_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/xen.12161","article-title":"Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1\/CMAH\/\u03b24GalNT2 genes","volume":"22","author":"Estrada","year":"2015","journal-title":"Xenotransplantation"},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/xen.12142","article-title":"Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation","volume":"22","author":"Salama","year":"2015","journal-title":"Xenotransplantation"},{"issue":"1","key":"10.1016\/j.trim.2025.102343_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12110","article-title":"Anti-gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits","volume":"140","author":"Galili","year":"2013","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12818","article-title":"Incidence of serum antibodies to xenoantigens on triple-knockout pig cells in different human groups","volume":"31","author":"He","year":"2024","journal-title":"Xenotransplantation"},{"issue":"8","key":"10.1016\/j.trim.2025.102343_bb0075","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/TP.0000000000002739","article-title":"HLA class I-sensitized renal transplant patients have antibody binding to SLA class I epitopes","volume":"103","author":"Martens","year":"2019","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/TP.0000000000001924","article-title":"Swine leukocyte antigen class II is a xenoantigen","volume":"102","author":"Ladowski","year":"2018","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.trim.2025.102343_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000746","article-title":"Rituximab and monitoring strategies for late antibody-mediated rejection after kidney transplantation","volume":"3","author":"Parajuli","year":"2017","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.trim.2025.102343_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903068","article-title":"Harnessing the B cell response in kidney transplantation - current state and future directions","volume":"13","author":"Anwar","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102343_bb0095","first-page":"686","article-title":"B cell immunity in solid organ transplantation","volume":"7","author":"Karahan","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trre.2017.01.002","article-title":"A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection","volume":"31","author":"Macklin","year":"2017","journal-title":"Transplant. Rev. (Orlando)"},{"issue":"9","key":"10.1016\/j.trim.2025.102343_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4049\/immunohorizons.2300056","article-title":"Patients on the transplant waiting list have anti-swine leukocyte antigen class I antibodies","volume":"7","author":"Wang","year":"2023","journal-title":"Immunohorizons"},{"issue":"4","key":"10.1016\/j.trim.2025.102343_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12816","article-title":"Antibody-mediated rejection in xenotransplantation: can it be prevented or reversed?","volume":"30","author":"Habibabady","year":"2023","journal-title":"Xenotransplantation"},{"issue":"9","key":"10.1016\/j.trim.2025.102343_bb0115","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102343_bb0120","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"12","key":"10.1016\/j.trim.2025.102343_bb0125","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.healun.2006.09.008","article-title":"Rituximab as monotherapy for elicited xenoreactive antibody responses","volume":"25","author":"Gonzalez-Stawinski","year":"2006","journal-title":"J. Heart Lung Transplant."},{"issue":"Suppl. 3","key":"10.1016\/j.trim.2025.102343_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102343_bb0135","author":"Genentech IaB"},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.2014.261","article-title":"A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation","volume":"87","author":"Jackson","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2025.102343_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101703","article-title":"Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients","volume":"75","author":"Razia","year":"2022","journal-title":"Transpl. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/TP.0000000000003303","article-title":"The role of SLAs in xenotransplantation","volume":"105","author":"Ladowski","year":"2021","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2025.102343_bb0155","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302214","article-title":"B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses","volume":"6","author":"Verhoeven","year":"2023","journal-title":"Life Sci Alliance."},{"key":"10.1016\/j.trim.2025.102343_bb0160","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.3324\/haematol.2019.231860","article-title":"Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients","volume":"105","author":"Frerichs","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.trim.2025.102343_bb0165","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1681\/ASN.2018121254","article-title":"Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use","volume":"30","author":"Kwun","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2025.102343_bb0170","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003505","article-title":"Daratumumab for antibody-mediated rejection in heart transplant-a novel therapy: successful treatment of antibody-mediated rejection","volume":"105","author":"Aguilera Agudo","year":"2021","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.trim.2025.102343_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14534","article-title":"Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients","volume":"27","author":"Cody","year":"2023","journal-title":"Pediatr. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2025.102343_bb0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ajt.12988","article-title":"Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons","volume":"15","author":"Le Bas-Bernardet","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102343_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5758\/vsi.220056","article-title":"Endovascular stent graft treatment of an iatrogenic symptomatic extracranial carotid-jugular arteriovenous fistula","volume":"38","author":"Ribeiro","year":"2022","journal-title":"Vasc. Spec. Int."},{"issue":"1","key":"10.1016\/j.trim.2025.102343_bb0190","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00007890-200001150-00025","article-title":"Interaction of anti-HLA antibodies with pig xenoantigens","volume":"69","author":"Barreau","year":"2000","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.trim.2025.102343_bb0195","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1097\/01.ASN.0000088723.07259.CF","article-title":"Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation","volume":"14","author":"D\u00edaz Varela","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.trim.2025.102343_bb0200","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molimm.2009.10.004","article-title":"Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation","volume":"47","author":"Mulder","year":"2010","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2025.102343_bb0205","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/TP.0000000000001646","article-title":"Humoral reactivity of renal transplant-waitlisted patients to cells from GGTA1\/CMAH\/B4GalNT2, and SLA class I knockout pigs","volume":"101","author":"Martens","year":"2017","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.trim.2025.102343_bb0210","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/TP.0000000000002060","article-title":"Immune responses of HLA highly sensitized and nonsensitized patients to genetically engineered pig cells","volume":"102","author":"Zhang","year":"2018","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.trim.2025.102343_bb0215","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/TP.0000000000000093","article-title":"Lack of cross-sensitization between \u03b1-1,3-galactosyltransferase knockout porcine and allogeneic skin grafts permits serial grafting","volume":"97","author":"Albritton","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2025.102343_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.TP.0000105116.74032.63","article-title":"Alloantibody and xenoantibody cross-reactivity in transplantation","volume":"77","author":"Cooper","year":"2004","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2025.102343_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-3089.2006.00319.x","article-title":"Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans","volume":"13","author":"Hara","year":"2006","journal-title":"Xenotransplantation"},{"issue":"3","key":"10.1016\/j.trim.2025.102343_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.trre.2015.04.003","article-title":"Anti-human leukocyte antigen DQ antibodies in renal transplantation: are we underestimating the most frequent donor specific alloantibodies?","volume":"29","author":"Carta","year":"2015","journal-title":"Transplant. Rev. (Orlando)"},{"issue":"11","key":"10.1016\/j.trim.2025.102343_bb0235","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1111\/ajt.15414","article-title":"Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation","volume":"19","author":"Senev","year":"2019","journal-title":"Am. J. Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:52:51Z","timestamp":1771638771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425001716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0966327425001716"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102343","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab-based antibody mediated rejection therapy modestly reduces Xenoreactive antibodies: Implications for pig-to-human xenotransplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102343"}}